title: Cost-benefits of new drugs.
authors.forename: D G
authors.initials: DG
authors.lastname: Daniel
authors.forename: C
authors.initials: C
authors.lastname: Moseley
authors.forename: S
authors.initials: S
authors.lastname: Rosenfield
authors.forename: S
authors.initials: S
authors.lastname: Wolf
authors.forename: S
authors.initials: S
authors.lastname: Nawroz
mesh_terms: D014150:Antipsychotic Agents / Q000009:adverse effects / Q000191:economics* / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy / Q000191:economics; D006801:Humans; D018967:Risperidone / Q000009:adverse effects / Q000191:economics* / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy / Q000191:economics; D016896:Treatment Outcome
chemical_list: D014150:Antipsychotic Agents; D018967:Risperidone